11.93
-1.44
(-10.77%)
At close: 4:00:02 PM EDT
11.91
-0.02
(-0.17%)
After hours: 4:20:57 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-157,410
-157,410
-99,910
-80,144
-53,716
Investing Cash Flow
-353,285
-353,285
-108,393
57,008
-22,619
Financing Cash Flow
410,906
410,906
361,077
42,678
1,393
End Cash Position
89,423
89,423
189,215
36,416
16,980
Capital Expenditure
--
--
--
-38
-573
Issuance of Capital Stock
405,232
405,232
366,474
42,874
--
Repayment of Debt
--
--
-16
-418
-510
Free Cash Flow
-157,410
-157,410
-99,910
-80,182
-54,289
12/31/2021 - 4/7/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APGE Apogee Therapeutics, Inc.
29.94
-5.85%
ORKA Oruka Therapeutics, Inc.
7.37
+2.79%
VRDN Viridian Therapeutics, Inc.
11.41
-3.22%
DNTH Dianthus Therapeutics, Inc.
15.60
-4.47%
CNTA Centessa Pharmaceuticals plc
11.27
-4.17%
VERA Vera Therapeutics, Inc.
21.81
-0.95%
XNCR Xencor, Inc.
7.92
-10.10%
CRNX Crinetics Pharmaceuticals, Inc.
26.85
-2.93%
EWTX Edgewise Therapeutics, Inc.
11.57
-7.44%
PHVS Pharvaris N.V.
11.90
-3.25%